Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
253.37
+4.17 (1.67%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Penumbra Market Cap
Penumbra has a market cap or net worth of $9.88 billion as of September 26, 2025. Its market cap has increased by 25.74% in one year.
Market Cap
9.88B
Enterprise Value
9.68B
1-Year Change
25.74%
Ranking
Category
Stock Price
$253.37
Market Cap Chart
Since September 18, 2015, Penumbra's market cap has increased from $1.23B to $9.88B, an increase of 701.85%. That is a compound annual growth rate of 23.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 9.88B | 8.41% |
| Dec 31, 2024 | 9.11B | -6.12% |
| Dec 29, 2023 | 9.71B | 14.91% |
| Dec 30, 2022 | 8.45B | -21.29% |
| Dec 31, 2021 | 10.73B | 68.92% |
| Dec 31, 2020 | 6.35B | 10.79% |
| Dec 31, 2019 | 5.74B | 36.03% |
| Dec 31, 2018 | 4.22B | 32.02% |
| Dec 29, 2017 | 3.19B | 58.19% |
| Dec 30, 2016 | 2.02B | 25.52% |
| Dec 31, 2015 | 1.61B | 30.52% |
| Sep 18, 2015 | 1.23B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |